BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19667977)

  • 1. Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1.
    Chisari C; Licitra R; Pellegrini M; Pellegrino M; Rossi B
    Clin Neuropharmacol; 2009; 32(6):330-4. PubMed ID: 19667977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.
    Chisari C; Bertolucci F; Dalise S; Rossi B
    J Neuroeng Rehabil; 2013 Aug; 10():94. PubMed ID: 23938156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.
    Milone M; Batish SD; Daube JR
    Muscle Nerve; 2009 Mar; 39(3):383-5. PubMed ID: 19208413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of apamin-sensitive K+ channels in myotonic dystrophy.
    Behrens MI; Jalil P; Serani A; Vergara F; Alvarez O
    Muscle Nerve; 1994 Nov; 17(11):1264-70. PubMed ID: 7935548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.
    Young NP; Daube JR; Sorenson EJ; Milone M
    Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcolemmal excitability in myotonic dystrophy: assessment through surface EMG.
    Chisari C; D'Alessandro C; Manca ML; Rossi B
    Muscle Nerve; 1998 Apr; 21(4):543-6. PubMed ID: 9533793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional electromyography in myotonic dystrophy.
    Caruso G; Ferrannini E
    Riv Patol Nerv Ment; 1976; 97(5):263-76. PubMed ID: 203018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
    Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
    Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental muscle pain decreases voluntary EMG activity but does not affect the muscle potential evoked by transcutaneous electrical stimulation.
    Farina D; Arendt-Nielsen L; Graven-Nielsen T
    Clin Neurophysiol; 2005 Jul; 116(7):1558-65. PubMed ID: 15907396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular excitability properties in myotonic dystrophy type 1.
    Boƫrio D; Hogrel JY; Bassez G; Lefaucheur JP
    Clin Neurophysiol; 2007 Nov; 118(11):2375-82. PubMed ID: 17890147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of electromyographical and mechanographical investigations in myotonia congenita (author's transl)].
    Wagner A; Zett L
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Mar; 13(1):14-21. PubMed ID: 6806065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface EMG analysis of sarcolemma excitability alteration and myofibre degeneration in Steinert disease.
    Chisari C; Simonella C; Rossi B
    Clin Neurophysiol; 2001 Oct; 112(10):1925-30. PubMed ID: 11595153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface EMG recording of heteronymous reflex excitation of semitendinosus motoneurones by group II afferents.
    Roujeau T; Decq P; Lefaucheur JP
    Clin Neurophysiol; 2004 Jun; 115(6):1313-9. PubMed ID: 15134698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experienced and physiological fatigue in neuromuscular disorders.
    Schillings ML; Kalkman JS; Janssen HM; van Engelen BG; Bleijenberg G; Zwarts MJ
    Clin Neurophysiol; 2007 Feb; 118(2):292-300. PubMed ID: 17166763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological features of patients with myotonic dystrophy type 1].
    Li M; Wang ZJ; Cui F; Yang F; Chen ZH; Ling L; Huang XS
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):345-7. PubMed ID: 23660205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal function and activity-dependent excitability changes in myotonic dystrophy.
    Krishnan AV; Kiernan MC
    Muscle Nerve; 2006 May; 33(5):627-36. PubMed ID: 16453325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatigue at various muscular lengths in myotonic dystrophy].
    Siciliano G; Diverio M; Rosellini P; Rossi B
    Riv Neurol; 1991; 61(5):191-6. PubMed ID: 1808679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.